Coinfección por el virus de la hepatitis C y el virus de la inmunodeficiencia humana: Implicaciones clínicas y biológicas

Medicina Clinica

Volumn 113, Issue 1, 1999, Pages 28-35

  Berenguer, Marina ^a   López Labrador, Francisco Xavier ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; REVIEW; TREATMENT INDICATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

HEPATITIS C; HIV INFECTIONS; HUMANS;

EID: 0033549305     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. McNair AN, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis 1992; 12: 188-196.
2. Moore R, Hidalgo J, Sugland B, Chaisson R. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1.412-1.416.
3. Vella S, Giuliano M, Pezzotti P, Agresti MG, Tomino C, Floridia M et al. Survival of zidovudina-treated patients with AIDS compared with that of contemporary untreated patients. JAMA 1992; 267: 1.232-1.236.
4. Soriano V, Valencia E, Alba A, Laguna F, Moreno V, Alberdi JC et al. Changing spectrum of diseases causing hospitalization in HIV-infected individuals. Med Clin (Barc) 1993; 101: 736-740.
5. Soriano V, García Samaniego J, Bravo R, Gutiérrez M, González-Lahoz J. High morbidity and mortality of chronic viral liver disease in HIV-Infected individuals in Spain. J Infect 1994; 28: 100-101.
6. Graham NMH, Zeger SL, Park LP, Vermund SH, Detels R, Rinaldo CR et al. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 1992; 326; 1.037-1.042.
7. Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Brechot C et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol 1998; 29: 12-19.
8. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
9. Schluger L, Sheiner P, Thung S, Lau J, Min A, Wolf D et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971-976.
10. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated inmune globulin. N Engl J Med 1994; 331: 1.607-1.611.
11. Domingo E, Menéndez-Arias L, Quiñones-Mateu ME, Holguín A, Gutiérrez-Rivas M, Martínez MA et al. Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. Prog Food Res 1997; 48: 99-128.
12. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients: prevalence and prognostic value. J Hepatol 1997; 27: 18-24.
13. Thomas DL, Zenilman JM, Alter HJ, Shih J, Galai N, Carella AV et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - an analysis of 309 sex parternships. J Infect Dis 1995; 171: 768-775.
14. García-Samaniego J, Soriano V, Silva E, Enríquez A, Muñoz F, Di Bisceglie A. Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third generation RIBA (RIBA-3) assay and PCR. Vox Sang 1994; 66: 48-49.
15. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. High hepatitis viremia and impaired antibody response in patients coinfected with HIV. AIDS 1995; 9: 1.131-1.136.
16. Marcellin P, Martinot-Peignoux M, Elias A, Branger M, Courtois F, Level R et al. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and seropositive patients with indeterminated HCV recombinant immunoblot assay. J Infect Dis 1994; 170: 433-435.
17. Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J et al. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) coinfection. J Med Virol 1997; 52: 219-222.
18. Eyster ME, Diamondstone LS, Lien JM, Ehman WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J AIDS 1993; 6: 602-610.
19. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko GM, Lee CA. The progression of HCV-associated liver disease in a cohort of hemophilia patients. Br J Haematol 1994; 87: 555-561.
20. Rockstroh JK, Spengler U, Sudhop T, Ewig S, Theisen A, Hammerstein U et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996; 91: 2.563-2.568.
21. García-Samaniego J, Soriano V, Castilla J, Bravo R, Moreno A, Carbó J et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Am J Gastroenterol 1997; 92: 1.130-1.134.
22. Soto B, Sánchez-Quijano A, Rodrigo L, Olmo JA, García-Bengoechea M, Hernández-Quero J et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26: 1-5.
23. Sánchez-Quijano A, Andreu J, Gavilán F, Luque F, Abad MA, Soto B et al. Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis 1995; 14: 949-953.
24. Sherman K, Andreatta C, O'Brien J, Gutiérrez A, Harris R. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 1996; 23: 688-694.
25. López-Labrador FX, Ampudarnés S, Forns X, Castells A, Séiz JC, Costa J et al. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997; 27: 959-965.
26. Lafon ME, Kirn A. Human immunodeficiency virus infection of the liver. Semin Liver Dis 1992; 12: 197-204.
27. Vento S, Garofano T, Renzini C, Casali F, Ferraro T, Concia E. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS 1998; 12: 116-117.
28. Sherman KE, O'Brien J, Gutiérrez AG, Harrison S, Ikdea M, Newald P et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993; 31: 2.679-2.682.
29. Evster ME, Fried MW, Di Biscieglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84: 1.020-1.023.
30. Telfer P, Brown D, Devereux H, Lee C, Dusheiko GM. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients. Br J Haematol 1994; 88: 397-399.
31. Cribier B, Schmidt C, Rey D, Uhl G, Lang JM, Vetter D et al. HIV increases hepatitis C viremia irrespective of the hepatitis C virus genotype. Res Virol 1997; 148: 257-271.
32. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174: 690-695.
33. Soriano V, Bravo R, Mas A, Garcia-Samaniego J, Gutiérrez M, González-Lahoz J. Impact of immunosuppression caused by HIV infection on the replication of hepatitis C virus. Vox Sang 1995; 69: 259-260.
34. Chambost H, Gerolami V, Halfon P, Thuret I, Michael G, Sicardi F et al. Persistent hepatitis C virus RNA replication in haemophilics: role of coinfection with human immunodeficiency virus. Br J Haemat 1995; 91: 703-707.
35. Ghany MG, Leissinger C, Lagier R, Sánchez-Pescador R, Lock AS. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996; 41: 1.265-1.272.
36. Havlir DV, Richman DD. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann Intern Med 1996; 124: 984-994.
37. Toyoda H, Fukuda Y, Koyama Y, Takamatsu J, Saito H, Hayakawa T. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 1997; 25: 975-982.
38. Bierhoff E, Fisher HP, Willsch E, Rockstroh J, Spengler U, Brackmann HH et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch 1997; 430: 271-277.
39. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995; 345: 289-291.
40. Dienstag J. Sexual and perinatal spread of hepatitis C virus infection. Hepatology 1997; 26 (Supl): 66-70.
41. Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata C, Kato M et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 744-750.
42. Soto B, Rodrigo L, Garcia-Bengoechea M, Sánchez-Quijano A, Riestra S, Arenas JI et al. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case: a multicenter study of 423 pairings. J Intern Med 1994; 236: 515-519.
43. Quan CM, Krajden M, Glynis A, Grigoriew GA, Salit IE. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis 1993; 17: 117-119.
44. Llibre JM, García E, Aloy A, Valls J. Hepatitis C virus infection and progression of infection due to human immunodeficiency virus [carta]. Clin Infect Dis 1993; 15: 182.
45. Wright TL, Hollander H, Pu X, Held MJ, Lipson P, Quan S et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 1994; 20: 1.152-1.155.
46. Dorucci M, Pezzotti P, Philips AN, Lepri AC, Rezza G. Italian Seroconversion Study. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J Infect Dis 1995; 172: 1.503-1.508.
47. Sabin C, Telfer P, Philips AN, Bhagany S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 1997; 175: 164-168.
48. Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998; 12: 381-388.
49. Eskild A, Magnus P, Brekke T, Bruun JN, Heger B, Froland SS et al. The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects. Scand J Infect Dis 1997; 29: 103-109.
50. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis 1994; 18: 339-347.
51. Giovannmi M, Tagger A, Ribero ML, Zucotti G, Pogliani L, Grossi A et al. Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction [carta]. Lancet 1990; 335: 1.166.
52. Hershow RC, Riester K, Lew J, Quinn T, Mofenson LM, Davenny K et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. J Infect Dis 1997; 176: 414-420.
53. Rodríguez EM, Mofenson LM, Chang BH, Rich KC, Fowler MG, Smeriglio V et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS 1996; 10: 273-282.
54. Lindsay K. Therapy of hepatitis C: overview. Hepatology 1997; 26 (Supl 1): 71-77.
55. Reichard O, Norkrans G, Frydén A, Braconier JH, Sönnerborg A, Weiland O, for the Swedish Study Group. Randomized, double-blind, placebo-controlled trial of interferon α-2b with or without ribavirin for chronic hepatitis C. Lancet 1998; 351: 83-87.
56. Boyer N, Marcellin P, Degott C, Degas F, Saimot AG, Erlingers S et al. Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. J Infect Dis 1992; 165: 723-726.
57. Marriott E, Navas S, Del Romero J, García S, Castillo I, Quiroga JA et al. Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV positive patients. J Med Virol 1993; 40: 107-111.
58. Soriano V, García-Samaniego J, Bravo R, Castro A, Odriozola PM, González J et al. Efficacy and safety of alfa-interferon treatment for chronic hepatitis C in HIV-infected patients. J Infect 1995; 31: 9-13.
59. Soriano V, García-Samaniego J, Bravo R, González J, Castro A, Castillo J et al. Interferon-alfa for the treatment of chronic hepatitis C in patients i-nfected with human immunodeficiency virus. Clin Infect Dis 1996; 23: 585-591.
60. Vento S, Di Perri G, Cruciani M, Garofano T, Concia E, Bassetti D. Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection [carta]. Lancet 1993; 341: 958-959.
61. Bouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994; 19: 854-859.